Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 and Vitamin E for Radiation Toxicity in Pelvic Cancers
NCT07668284Phase 2Not yet recruiting
- Sponsor
- University of Nebraska
- Start
- Dec 2026
- Primary completion
- Feb 2030
- Countries
- 1
01
Overview
A Phase 2 trial of Coenzyme Q10 mucoadhesive tablets, vitamin e in acute radiation syndrome (ARS), sponsored by University of Nebraska. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
Coenzyme Q10 mucoadhesive tabletsvitamin e
03
Conditions
acute radiation syndrome (ARS)
Beyond the preview
Go deeper on NCT07668284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668284.